Clinical trials
Dyslipidemias trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The George Institute for Global Health, China | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Amway (China) R&D Center | 1 |
| AstraZeneca | 1 |
| China Medical University, China | 1 |
| First Hospital of China Medical University | 1 |
| Jiangxi University of Traditional Chinese Medicine | 1 |
| Shaochun.Li | 1 |
| Shaoguan University | 1 |
| Southeast University, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 14 |
| Hypertension | 6 |
| Diabetes Mellitus | 5 |
| Cardiovascular Diseases | 3 |
| Obesity | 2 |
| Overweight | 2 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hyperlipidemias | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.